PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 67 filers reported holding PASSAGE BIO INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,648,629 | -29.8% | 2,497,922 | 0.0% | 2.12% | +5.0% |
Q2 2023 | $2,348,047 | -2.1% | 2,497,922 | 0.0% | 2.02% | +1.8% |
Q1 2023 | $2,398,005 | -30.4% | 2,497,922 | 0.0% | 1.98% | -20.6% |
Q4 2022 | $3,447,132 | +10.4% | 2,497,922 | 0.0% | 2.50% | +34.8% |
Q3 2022 | $3,122,000 | -47.0% | 2,497,922 | 0.0% | 1.85% | -51.5% |
Q2 2022 | $5,895,000 | -23.9% | 2,497,922 | 0.0% | 3.82% | +0.1% |
Q1 2022 | $7,744,000 | -51.2% | 2,497,922 | 0.0% | 3.82% | -33.6% |
Q4 2021 | $15,862,000 | -36.2% | 2,497,922 | 0.0% | 5.75% | -19.9% |
Q3 2021 | $24,879,000 | +1591.3% | 2,497,922 | 0.0% | 7.18% | +1798.4% |
Q2 2021 | $1,471,000 | -96.6% | 2,497,922 | 0.0% | 0.38% | -96.3% |
Q1 2021 | $43,664,000 | -31.6% | 2,497,922 | 0.0% | 10.16% | -31.1% |
Q4 2020 | $63,872,000 | +95.0% | 2,497,922 | 0.0% | 14.76% | +11.8% |
Q3 2020 | $32,748,000 | -52.0% | 2,497,922 | 0.0% | 13.20% | -32.6% |
Q2 2020 | $68,268,000 | +73.5% | 2,497,922 | 0.0% | 19.59% | +66.4% |
Q1 2020 | $39,342,000 | – | 2,497,922 | – | 11.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,959,769 | $49,399,000 | 20.45% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,185,869 | $11,811,000 | 9.97% |
New Leaf Venture Partners, L.L.C. | 2,497,922 | $24,879,000 | 7.18% |
FRAZIER MANAGEMENT LLC | 5,009,219 | $49,892,000 | 3.99% |
Orbimed Advisors | 6,962,899 | $69,350,000 | 0.76% |
Boxer Capital, LLC | 1,928,315 | $19,206,000 | 0.67% |
Vivo Capital, LLC | 539,263 | $5,371,000 | 0.24% |
Logos Global Management LP | 125,010 | $1,245,000 | 0.09% |
Weiss Multi-Strategy Advisers LLC | 336,034 | $3,347,000 | 0.07% |
Virtus ETF Advisers LLC | 14,687 | $146,000 | 0.06% |